dextrose
Small moleculeexperimental
Acid-citrate-dextrose or acid-citrate-dextrose solution is any solution of citric acid, sodium citrate, and dextrose in water. It is mainly used as an anticoagulant to preserve blood specimens required for tissue typing. It is also used during procedures such as plasmapheresis instead of heparin. — Wikipedia
Clinical trial activity
165 trials · 184 clinical orgs · 0 marketing orgs
Phase 1
17
Phase 2
30
Phase 3
15
Phase 4
29
Earliest trial started Jan 31, 2007 (NCT01343758)
Timeline
Indications
Approved for
Studied for
- Acidosis · Phase 3
- Acute Coronary Syndrome · Phase 2
- Adolescent Behavior · Early Phase 1
- Air Travel · Phase 2/Phase 3
- Anesthesia · Phase 2/Phase 3
- Arrhythmias, Cardiac · Phase 1
- Arthritis · Phase 2/Phase 3
- Arthropathy, Neurogenic · Phase 2/Phase 3
- Back Pain · Phase 3
- Bacterial Infections · Phase 1
- Blood Pressure · Early Phase 1
- Body Weight · Phase 2
- Brain Injuries, Traumatic · Phase 1
- Breast Neoplasms · Phase 3
- Bursitis · Phase 4
- Carpal Tunnel Syndrome · Phase 4
- Cesarean Section · Phase 4
- Chronic Pain · Phase 4
- Colonic Diseases · Phase 4
- Constipation · Phase 2
- COVID-19 · Phase 3
- Critical Illness · Phase 2
- Dehydration · Phase 4
- Dermatitis, Atopic · Phase 3
- Diabetes, Gestational · Phase 2
- Diabetes Mellitus, Type 1 · Phase 2
- Diabetes Mellitus, Type 2 · Phase 4
- Dietary Sugars · Phase 4
- Dronabinol · Early Phase 1
- Ehlers-Danlos Syndrome · Phase 3
- Exercise · Phase 4
- Female · Early Phase 1
- Fibrosis · Phase 4
- Gastroschisis · Phase 1
- Glucose Intolerance · Phase 2
- Gynecologic Surgical Procedures · Phase 4
- Healthy Volunteers · Phase 4
- Hepatitis, Alcoholic · Phase 2
- Hyperglycemia · Phase 2
- Hyperinsulinism · Phase 1
- Hyperkalemia · Phase 4
- Hypernatremia · Phase 4
- Hypertension · Early Phase 1
- Hypoglycemia · Phase 4
- Hypokalemia · Phase 4
- Hyponatremia · Phase 4
- Influenza, Human · Phase 4
- Injections · Phase 4
- Insulin Resistance · Phase 2
- Intestinal Diseases · Phase 4
- Ischemic Stroke · Phase 2
- Kidney Failure, Chronic · Phase 2
- Knee Injuries · Phase 4
- Labor, Induced · Phase 4
- Liver Diseases · Phase 2/Phase 3
- Low Back Pain · Phase 3
- Lung Diseases · Phase 2
- Meniscus · Phase 4
- Myocardial Infarction · Phase 1
- Myocardial Reperfusion Injury · Phase 1
- Myofascial Pain Syndromes · Phase 4
- Obesity · Phase 4
- Osteoarthritis, Knee · Phase 4
- Pain · Phase 4
- Pancreatic Diseases · Phase 2/Phase 3
- Patient Satisfaction · Phase 3
- Peritoneal Dialysis · Phase 4
- Pharmacokinetics · Phase 4
- Physical Therapy Modalities · Phase 4
- Post-Dural Puncture Headache · Phase 4
- Post-Lyme Disease Syndrome · Early Phase 1
- Postoperative Complications · Phase 3
- Postural Balance · Phase 4
- Prediabetic State · Phase 2
- Psychotic Disorders · Phase 2
- Renal Dialysis · Phase 2
- Reperfusion Injury · Phase 1
- Respiratory Distress Syndrome · Phase 2
- Respiratory Insufficiency · Phase 2
- Rotator Cuff Injuries · Phase 2/Phase 3
- Schizophrenia · Phase 2
- Sepsis · Phase 2
- Shock · Phase 3
- Shoulder Injuries · Phase 4
- Sodium · Phase 2
- Sprains and Strains · Phase 2
- Systemic Inflammatory Response Syndrome · Phase 4
- Temporomandibular Joint Disorders · Phase 2/Phase 3
- Tennis Elbow · Phase 4
- Water-Electrolyte Balance · Phase 4
Mechanism of action
- Unspecified targetSupplementation
supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- Yes
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaAcid-citrate-dextrose ↗
- ChEMBLCHEMBL2107958 ↗
- WikipediaPolydextrose ↗
- WikipediaGlucose ↗
Also known as
- citrate dextrose
- cp-31081
- polydextrose
- polydextrose
- polydextrose
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07283874 | Phase 4 | Dec 31, 2025 | Assiut University |
| NCT06936709 | Phase 4 | Dec 1, 2025 | Geisinger Clinic |
| NCT07233382 | N/A | Dec 1, 2025 | Hayatabad Medical Complex |
| NCT07296653 | Early Phase 1 (Phase 1) | Dec 1, 2025 | University of Athens |
| NCT07245121 | N/A | Nov 30, 2025 | University of Athens |
| NCT07169890 | N/A | Nov 1, 2025 | MTI University |
| NCT06872645 | N/A | Oct 3, 2025 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Yale University |
| NCT07129681 | N/A | Oct 1, 2025 | Cairo University |
| NCT07124130 | Phase 4 | Sep 30, 2025 | Eastern Virginia Medical School, University of Modena and Reggio Emilia |
| NCT07008456 | Phase 2 | Sep 12, 2025 | Aphaia Pharma US LLC |
| NCT07105540 | Phase 4 | Aug 5, 2025 | Ankara Etlik City Hospital |
| NCT07075822 | N/A | Jun 11, 2025 | Anderson Advanced Ingredients, Inquis Clinical Research |
| NCT06935552 | Early Phase 1 (Phase 1) | Jun 1, 2025 | Assiut University |
| NCT07241559 | N/A | May 20, 2025 | Ankara Yildirim Beyazıt University, University of Ankara |
| NCT06859034 | Phase 2/Phase 3 (Phase 3) | Mar 3, 2025 | Cairo University |
| NCT06881316 | N/A | Feb 10, 2025 | Gaziosmanpasa University |
| NCT06755697 | N/A | Jan 23, 2025 | Shin Kong Wu Ho-Su Memorial Hospital |
| NCT07002892 | N/A | Jan 1, 2025 | Ankara Etlik City Hospital |
| NCT06726980 | Phase 4 | Jan 1, 2025 | Assiut University |
| NCT06988228 | N/A | Dec 24, 2024 | Istanbul Physical Medicine Rehabilitation Training and Research Hospital |
Showing 20 of 165 trials
Page 1 / 9
Organizations
Research & Development (184)
184 organizations
Page 1 / 10